Wells Fargo’s Boston Scientific BSX Stock Holding History

Wells Fargo’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.9M	Buy	285,000 +56,700	+25%	+$4.54M	﹤0.01%	1588
2025 Q4	$21.8M	Buy	+228,300	New	+$22.4M	﹤0.01%	1445
2025 Q1	–	Sell	-20,000	Closed	-$1.79M	–	7050
2024 Q4	$1.79M	Buy	+20,000	New	+$1.76M	﹤0.01%	3276
2022 Q2	–	Sell	-11,900	Closed	-$527K	–	6825
2022 Q1	$527K	Buy	11,900 +11,700	+5,850%	+$507K	﹤0.01%	4369
2021 Q4	$8K	Buy	+200	New	+$8.4K	﹤0.01%	6610
2021 Q3	–	Sell	-12,000	Closed	-$513K	–	6983
2021 Q2	$513K	Buy	+12,000	New	+$505K	﹤0.01%	4603
2020 Q4	–	Sell	-38,000	Closed	-$1K	–	6498
2020 Q3	$1K	Sell	38,000 -637,000	-94%	-$24.5M	﹤0.01%	6182
2020 Q2	$291K	Buy	+675,000	New	+$24.3M	﹤0.01%	4679
2019 Q3	–	Sell	-90,800	Closed	-$80K	–	6379
2019 Q2	$80K	Buy	+90,800	New	+$3.49M	﹤0.01%	5393
2019 Q1	–	Sell	-229,800	Closed	-$111K	–	6057
2018 Q4	$111K	Buy	229,800 +183,800	+400%	+$6.67M	﹤0.01%	5232
2018 Q3	$25K	Buy	+46,000	New	+$1.61M	﹤0.01%	5772

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's BSX Position: Q1 2026 in Review

Wells Fargo reduced its Boston Scientific (BSX) stake by 28% in Q1 2026, selling an estimated $93.3M and leaving 2,971,322 shares worth $186M. The position accounts for 0.04% of the portfolio, ranked #412.

Wells Fargo first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $493M in Q4 2019. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Wells Fargo held 2,971,322 shares of Boston Scientific worth $186M as of Q1 2026.
Wells Fargo sold 1,165,706 Boston Scientific shares in Q1 2026, an estimated $93.3M.
Boston Scientific made up 0.04% of Wells Fargo's portfolio in Q1 2026, its #412 holding.
Wells Fargo first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Boston Scientific position peaked at $493M in Q4 2019.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.